期刊文献+

牦牛CCL14蛋白对HepG2细胞活性和凋亡的影响

Effects of Yak CCL14 Protein on Activity and Apoptosis of HepG2 Cells
下载PDF
导出
摘要 旨在研究牦牛CCL14蛋白(Bos grunniens C-C motif chemokine 14 protein,BgCCL14)对HepG2细胞的影响和作用机制。将原核表达的BgCCL14蛋白与HepG2细胞共培养,利用CCK-8试剂盒检测细胞活性,平板克隆检测细胞克隆形成能力,细胞划痕检测细胞迁移以及荧光定量PCR检测相关基因的表达量。结果表明,1μg/mL、10μg/mL和20μg/mL的BgCCL14蛋白均能显著降低HepG2细胞活性;20μg/mL的BgCCL14蛋白对细胞增殖和迁移有极显著抑制作用;20μg/mL的BgCCL14蛋白处理36h极显著上调凋亡基因BAK和BAX的mRNA水平,极显著降低HIF1A、PI3K和CDK1基因的mRNA水平,显著降低mTOR基因的mRNA水平。这表明BgCCL14蛋白可能通过促进细胞凋亡抑制肝癌细胞活性。 The aim of this study is to study the effect of Bos grunnies C-C motif chemokine 14 protein(BgCCL14)on HepG2 cells and its mechanism.HepG2 cells were co-cultured with prokaryotic ex­pressed BgCCL14 protein.The cell viability was detected by CCK-8 kit,the ability of cell clone forma­tion was detected by plate clone,the cell migration was detected by scratch test,and the expression of related genes was detected by qPCR.The results showed that BgCCL14 protein of 1 μg/mL,10 μg/mL and 20 μg/mL significantly decreased the viability of HepG2 cells.And BgCCL14 protein of 20 μg/mL significantly inhibited cell proliferation and migration.In addition,BgCCL14 protein of 20 μg/mL extremely significant up-regulate the mRNA levels of apoptotic genes BAK and BAX in 36 h,and decreased mRNA levels of HIF1A,P13K,and CDK1 genes.And the mRNA levels of mTOR al­so significantly decreased.So BgCCL14 may affect viability of HepG2 cells and promotes its apoptosis.This study will benefit for further study of the function of CCL14.
作者 梅群弟 李娟 王利 MEI Qundi;LI Juan;WANG Li(The Key Laboratory of Animal Science of State Ethnic Affairs Commission,Southwest Minzu University,Chengdu 610041,China)
出处 《西北农业学报》 CAS CSCD 北大核心 2023年第4期527-533,共7页 Acta Agriculturae Boreali-occidentalis Sinica
基金 西南民族大学中央高校基本科研业务专项(2021PTJS26) 四川省留学人员科技活动择优资助项目(2019)。
关键词 CCL14 HEPG2细胞 凋亡 CCL14 HepG2 cells Apoptosis
  • 相关文献

参考文献11

二级参考文献113

  • 1游龙贵,孙炜,孙彦,张克辉,张小安,兰玉清.喉癌手术切缘Bcl-2、Bax及Bak蛋白的表达[J].青岛大学医学院学报,2005,41(1):40-42. 被引量:8
  • 2侯如燕,宛晓春,吴慧平.油茶总皂甙抑菌活性的初步研究[J].食品科学,2006,27(1):51-54. 被引量:18
  • 3Clohessy JG et al. Mcl-I interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor- mediated apoptosis. JBiol Chem, 2006, 281 : 5750-5759.
  • 4Green DR et al. Mitochondria and apoptosis. Science, 1998, 281: 1309-1312.
  • 5Rahmani Met al. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem, 2005, 280: 35217-35227.
  • 6Bain Jet al. The specificities of protein kinase inhibitors: an update. Biochem J, 2003, 371 : 199-204.
  • 7Kane RC et al. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist, 2003, 8:508-513.
  • 8Kane RC et al. Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res, 2007, 13:5291-5294.
  • 9Kane RC et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res, 2006, 12:2955-2960.
  • 10Chen S et al. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res, 2007, 67:782-791.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部